- In August 2024, Tarsus Pharmaceuticals is gaining commercial momentum after the approval of Xdemvy for treating Demodex blepharitis, a prevalent but often misunderstood eyelid condition caused by Demodex mite infestations. The drug, approved in the previous summer, has started to make an impact in the market. Its availability is helping to address the unmet need for effective treatments for this chronic eye condition
- In June 2023, the FDA granted approval for Tarsus Pharmaceuticals' Xdemvy as the first FDA-approved treatment for Demodex blepharitis, a condition affecting the eyelids. This approval marks a significant milestone in the management of blepharitis. Xdemvy's introduction provides a new therapeutic option for patients suffering from this chronic eye condition
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Anterior Blepharitis and Posterior Blepharitis), Treatment Type (Warm Compresses or Eyelid Scrubs, Mechanical Glandular Eyelid Massage, Artificial Lubricants, Topical Antibiotics, Topical Corticosteroids, Combination Topical Corticosteroids and Antibiotic, Meibomian Gland Expression, Oral Antibiotics and Dietary Supplements), Dosage Form Type (Tablets, Solution, Suspension, Ointment, and Others), Route of Administration (Oral, Topical, and Others), End Users (Hospitals, Homecare, Specialty Clinics, and Others)– Industry Trends and Forecast to 2032
.
The Global Blepharitis Drug Market size was valued at USD 1.16 USD Billion in 2024.
The Global Blepharitis Drug Market is projected to grow at a CAGR of 5% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
